Sanofi officially extends Genzyme tender; Lundbeck chairman to step down;

@FiercePharma: Patent cliff jeopardizes $250B in sales through 2015. Story | Follow @FiercePharma

> French drugmaker Sanofi-Aventis has officially extended its offer for all outstanding shares of U.S. biotech Genzyme until April 1 from March 16. News

> Danish drugmaker Lundbeck said its chairman of the board, Per Wold-Olsen, would not seek re-election at the company's upcoming shareholders' meeting. Report

> A Boston federal court has certified a class action lawsuit against McKesson on behalf of municipalities that sued the drug distributor in 2008 for alleged drug overcharges. Story

> Activist hedge fund Elliott Advisors said it has launched a website to help investors in Europe's biggest biotech Actelion vote at the company's shareholder meeting. Article

> A fierce battle is being waged between retail pharmacists and mail-order companies over where people should be able to fill their long-term prescriptions. Story

> Belgian pharmaceutical group UCB launched perpetual subordinated bonds worth €300 million ($419.7 million) to further improve its financial structure. Item

> A switch in focus from talk therapy to medications has swept psychiatric practices and hospitals, leaving many older psychiatrists feeling unhappy and inadequate. News

> Ista Pharmaceuticals filed a petition with FDA, asking it to refrain from approving a generic form of a discontinued cataract drug using the original labeling. Article

> TestPak, a pharmaceutical packaging and repackaging company based in Whippany, NJ, has merged with three other companies and changed its name. Story

Biotech News

@FierceBiotech: Pfizer's blockbuster RA hopeful clears a Ph3 hurdle. News | Follow@FierceBiotech

@JohnCFierce: Lilly's neuroscience chief wasn't kicked out, he was recruited by J&J. Article | Follow @JohnCFierce

> Fact or Fantasy? Investigators estimate new drug R&D at $55M. Story 

> NYT: Big Pharma hits the panic button as new programs fail to deliver. Report

> Biogen scouting for new hematology programs to buy, license. Article 

> AZ opens its R&D cupboards to Galderma in dermatology pact. News

> Genzyme's Termeer to pocket up to $221M. Item

 Biotech IT News

> Former MS programmer assails software patents. Report 

> Contractors tap SharePoint as EDM platform. Article 

> Indiana site connects researchers with trial subjects. News 

> Oracle rouses Phase Forward in coding release. Report 

> SAS, JMP visualize safety review data. Item 

> App combo links imaging, randomization. Story

Medical Device News

> Accuray to buy TomoTherapy for $277M. News 

> Japan's Terumo buys Caridian for $2.6B. Article 

> Medtronic launches Achieve Mapping Catheter in Europe. Story 

> Aussie firms look to make bionic eye as Argus II gets EU OK. Report

> NASA tech reduces common chemo side effect. Item

And Finally... After hours, Sanofi-Aventis chemist Antonio Ramos puts his skill set to a different use: developing formulas for Brooklyn Soda Works, the artisanal soda company he started last year with his partner. Report

Suggested Articles

With a pack of drugmakers angling for COVID-19 vaccine approvals in the coming months, the task of global distribution is more important than ever. Wi

"We have a chance to improve our reputation if we deliver on our purpose to find solutions responsibly," GSK CEO Emma Walmsley said.

The FDA knocked India's Panacea Biotec for failing to adequately identify isolated microbes in its aseptic manufacturing facility.